[{"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7129", "0904-7130", "0904-7131", "0904-7132", "0904-7133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["be5824c1-1eca-44db-a689-c67b9808c1f9"], "spl_set_id": ["d58570a0-58b0-4662-b2ad-aa8d1463b4c1"], "package_ndc": ["0904-7129-61", "0904-7130-61", "0904-7130-06", "0904-7131-61", "0904-7132-61", "0904-7133-61", "0030904713"], "original_packager_product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "unii": ["9WP59609J6"], "upc": ["003090471316"]}, "product_type": "Drugs", "event_id": "97584", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0011-2026", "product_description": "Major ChlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100 Tablets, (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7131-61, UPC (01)00309047131617", "product_quantity": "506 blister packs", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit", "recall_initiation_date": "20250912", "center_classification_date": "20251007", "report_date": "20251015", "code_info": "Lots N02009 & N02026, exp. date 02/28/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0131-2016", "product_description": "TESTOSTERONE, Pellet, 120 mg,  Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "20 pellets", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t12052014@18, t11252014@19, t11192014@18, t11112014@4, t09192014@18, t09102014@20, t08272014@10, t06242015@30, t06022015@8, t05202015@11, t05042015@22, t05012015@17, t04102015@4, t03302015@21, t03202015@18, t03052015@12, t02252015@10, t01302015@23, t01232015@24, t01142015@21."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0435-2018", "product_description": "Midazolam HCl in 5% Dextrose in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202868"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-357"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["312504"], "spl_id": ["b0251572-aa7f-434a-a7ff-33ccbc37dfaf"], "spl_set_id": ["5b054142-7372-4641-be27-dca630a97ad9"], "package_ndc": ["68462-357-90", "68462-357-01", "68462-357-05"], "is_original_packager": [true], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "94715", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0606-2024", "product_description": "Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India, Manufactured for: Glenmark Pharmaceuticals Inc, USA, Mahwah, NJ 07430. NDC 68462-357-01", "product_quantity": "", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240530", "center_classification_date": "20240717", "report_date": "20240724", "code_info": "Lot #:  17230074, 17230221, Exp Dec-31-24; 17230468, 17230479, 17230553, 17230543, 17230561, Exp Jan-31-25; 17230619, 17230624, Exp Feb-28-25; 17230879, 17230890, 17230918, 17230984, 17230996, 17231002, 17231081, Exp Mar-31-25; 17231102, 17231135, 17231329, Exp Apr-30-25; 17231369, 17231513, Exp May-31-24; 17231516, 17231713, Exp Jun-30-25; 17231909, 17231903, Exp Jul-31-25; 17231943, Exp Aug-31-25; 17232166, 17232179, Exp Sep-30-25.", "more_code_info": ""}, {"status": "Terminated", "city": "Corpus Christi", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76235", "recalling_firm": "MOORE'S COMPOUNDING PHARMACY", "address_1": "5945 McArdle Rd Ste 101", "address_2": "N/A", "postal_code": "78412-3491", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "TX", "recall_number": "D-0488-2017", "product_description": "Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX", "product_quantity": "90 capsules", "reason_for_recall": "Superpotent Drug and Subpotent Drug; potency failures obtained", "recall_initiation_date": "20160912", "center_classification_date": "20170221", "termination_date": "20170517", "report_date": "20170301", "code_info": "2016-08-22:37@28, exp 2/18/2017"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["RAPIDOL"], "generic_name": ["HYDROCORTISONE"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-420"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROCORTISONE"], "rxcui": ["106258"], "spl_id": ["25a3aeec-2ce5-6614-e063-6294a90a2ae5"], "spl_set_id": ["19a1f1e2-bc6b-7153-e063-6294a90ab115"], "package_ndc": ["55758-420-02"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["WI4X0X7BPJ"], "upc": ["810096771582"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0428-2025", "product_description": "Rapidol Maximum Strength, Hydrocortisone 1% Anti-Itch Cream, NET WT 2 oz (60g) Tube, Distributed by: Pharmadel LLC, New Castle, DE, 19720, NDC 55758-420-02, UPC 8 10096 77158 2.", "product_quantity": "10,000 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot SP26A, Exp: 09/30/2026"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0687-2020", "product_description": "BUP 17MG/MORP 22MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@25 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Marietta", "state": "GA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA205327"], "brand_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "generic_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "manufacturer_name": ["Trigen Laboratories, LLC"], "product_ndc": ["13811-706", "13811-709", "13811-707", "13811-708", "13811-710"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "rxcui": ["1091155", "1091170", "1091185", "1091210", "1995461"], "spl_id": ["54f7316b-8a84-4145-aecf-f380afbf261b"], "spl_set_id": ["c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"], "package_ndc": ["13811-709-10", "13811-706-10", "13811-707-10", "13811-708-10", "13811-710-10", "13811-710-30"], "is_original_packager": [true], "upc": ["0313811706109", "0313811709100", "0313811708103", "0313811707106"], "unii": ["4B3SC438HI"]}, "product_type": "Drugs", "event_id": "78764", "recalling_firm": "Osmotica Pharmaceutical Corp", "address_1": "895 Sawyer Rd", "address_2": "", "postal_code": "30062-2257", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0110-2018", "product_description": "Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles,  Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08807, NDC 13811-707-10", "product_quantity": "10064 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20171218", "center_classification_date": "20171220", "termination_date": "20190501", "report_date": "20171227", "code_info": "Lot #: 170027A, Exp. 02/2019", "more_code_info": ""}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0488-2022", "product_description": "PAIN TERMINATOR extra strength pain relief (aspirin 162 mg, acetaminophen 110 mg, Caffeine 32.4mg, Salicylamide 152 mg) 2 tablet packets, Manufactured for: Tellus Medical Products, Palm Desert, CA 92211, NDC 69103-2507", "product_quantity": "1,188,280 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9451, Exp. Date 01/2022"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA091650"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-121", "55111-122", "55111-123"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["617310", "617311", "617312"], "spl_id": ["36e09eff-3948-2638-b633-d5ec2bc03d2a"], "spl_set_id": ["901550e6-22be-68c9-eb86-f85a9c9dd998"], "package_ndc": ["55111-121-30", "55111-121-60", "55111-121-90", "55111-121-05", "55111-121-10", "55111-122-30", "55111-122-60", "55111-122-90", "55111-122-05", "55111-122-10", "55111-123-30", "55111-123-60", "55111-123-90", "55111-123-05", "55111-123-10"], "is_original_packager": [true], "upc": ["0355111123903"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "87365", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0291-2021", "product_description": "Atorvastatin Calcium Tablets, 40mg, packaged in a) 90-count bottles, NDC 55111-123-90; b)  500-count bottles, NDC 55111-123-05; Rx only, Mfd By: Dr. Reddy's Laboratories Limited Srikakulam - 532 409 INDIA", "product_quantity": "10,440 90-count and 224,710 500-count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:presence of ATV cyclo IP and FP, Dihydroxy epoxy and Dieto epoxy impurities", "recall_initiation_date": "20210219", "center_classification_date": "20210301", "termination_date": "20230907", "report_date": "20210310", "code_info": "a) T900406, exp 3/2021    b) T000078 exp 12/2021  T000079 exp 12/2021  T000080 exp 12/2021  T000081 exp 12/2021  T000082 exp 12/2021  T000083 exp 12/2021  T000084 exp 12/2021  T000085 exp 12/2021  T000086 exp 12/2021  T000087 exp 12/2021  T000088 exp 1/2022  T000311 exp 1/2022  T000312 exp 1/2022  T000313 exp 1/2022  T000314 exp 1/2022  T000315 exp 1/2022  T000316 exp 1/2022  T000317 exp 1/2022  T000318 exp 1/2022  T000319 exp 1/2022  T000320 exp 1/2022  T000500 exp 2/2022  T000501 exp 2/2022  T000502 exp 2/2022  T000503 exp 2/2022  T000504 exp 2/2022  T000505 exp 2/2022  T000506 exp 2/2022  T000507 exp 2/2022  T000508 exp 2/2022  T000509 exp 3/2022  T000510 exp 3/2022  T000647 exp 3/2022  T000648 exp 3/2022  T000651exp 3/2022  T000652 exp 3/2022  T000653 exp 3/2022  T000654 exp 3/2022  T000875 exp 4/2022  T000876 exp 4/2022  T000877 exp 4/2022  T000878 exp 4/2022  T000879 exp 4/2022  T000880 exp 4/2022  T000881 exp 4/2022  T000882 exp 4/2022  T000883 exp 4/2022  T000884 exp 4/2022  T001120 exp 5/2022  T001121 exp 5/2022  T001122 exp 5/2022  T001124 exp 5/2022  T001125 exp 5/2022  T001126 exp 5/2022  T001127 exp 5/2022  T001128 exp 5/2022  T001129 exp 5/2022  T001130 exp 5/2022  T001260 exp 5/2022  T001261 exp 5/2022  T900506 exp 4/2021  T900507 exp 4/2021  T900508 exp 4/2021  T900655 exp 5/2021  T900656 exp 5/2021  T900657 exp 5/2021  T900658 exp 5/2021  T900659 exp 5/2021  T900673 exp 5/2021  T900674 exp 5/2021  T901024 exp 7/2021  T901025 exp 7/2021  T901026 exp 7/2021  T901027 exp 7/2021  T901029 exp 7/2021   T901030 exp 7/2021  T901031 exp 7/2021  T901032 exp 7/2021  T901033 exp 7/2021  T901424 exp 10/2021  T901425 exp 10/2021  T901426 exp 10/2021  T901427 exp 10/2021   T901428 exp 10/2021  T901429 exp 10/2021  T901430 exp 10/2021   T901431 exp 10/2021  T901432 exp 10/2021  T901433 exp 10/2021  T901568 exp 10/2021  T901569 exp 10/2021  T901570 exp 11/2021  T901571 exp 11/2021  T901572 exp 11/2021  T901573 exp 11/2021  T901574 exp 11/2021  T901575 exp 11/2021  T901576 exp 11/2021  T901577 exp 11/2021", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "10 pellets", "code_info": "All lots distributed between November 2014 and May 2015;  03112015@11, 9/7/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Estradiol 3 mg, Sterile Pellet, The Compounding Pharmacy of America, Inc., Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1472-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DIGOXIN, Tablet, 125 mcg may have potentially been mislabeled as the following drug:  CHOLECALCIFEROL/ CALCIUM/ PHOSPHORUS, Tablet, 120 units/105 mg/81 mg, NDC 64980015001, Pedigree: W002581, EXP: 6/3/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "DIGOXIN, Tablet, 125 mcg has the following codes:   Pedigree: AD76675_4, EXP: 6/3/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DIGOXIN, Tablet, 125 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00527132401.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-919-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "3 units", "code_info": "Rx #'s:   0358393    0400281", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CYCLOPENT/KETOROLAC/PHENYLEPH/TROPICAMIDE 1%/0.5%/2.5%/1% OPHTHALMIC 70 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1490-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0022-2025", "product_description": "EPINEPHrine 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-060-58", "product_quantity": "753 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000038958, exp. date 17-Oct-24 C274-000039206, exp. date 23-Oct-24", "more_code_info": ""}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0765-2018", "product_description": "Copaxone 40 mg Injection (12) NDC 68546-0325-12 28 days supply.", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "5303 Cases", "code_info": "Product Code: 6552; Lots: 52573, 52926,  53596, EXP 10/03/2017; 53610, 54288, EXP 12/19/2017; 54723, EXP 02/27/2018; 55878, 55890, 56617, 56637, EXP 04/24/2018; 56644, 56647, 56652, 57299, 57317, EXP 06/12/2018; 57305, EXP 05/08/2018; 57321, 60919, 61943, 58386, EXP 08/07/2018; 58398, EXP 10/02/2018; 59723, EXP 10/16/2018; 59739, EXP 12/11/2018;", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Toothette Oral Care Suction Swab System with Perox-A-Mint Solution, Contains 6 Packages of 2 Suction Swabs with sodium, bicarbonate and a .25 fl oz/7ml pouch of Perox-A-Mint solution, 2 Packages of 1 Suction Toothbrush with sodium bicarbonate and a .25 fl oz/7ml pouch of Perox-A-Mint solution, 10 Applicator Swabs, .5 oz/14g tube of Mouth Moisturizer. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6552 UPC 6 18029 82115 7", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0381-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Glendale", "address_1": "655 N Central Ave Fl 17 Ste 1704a", "reason_for_recall": "CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.", "address_2": "", "product_quantity": "8 kgs", "code_info": "Lot # 170501", "center_classification_date": "20181005", "distribution_pattern": "Distributed to two compounding firms in Minnesota.", "state": "CA", "product_description": "Thyroid powder, 4.5 kg foil bag, 5x1 kg foil bags packed in 25 Kg Fiber Drum, Thyroid Powder 25kg/drum, US Pharmacopoeia, Sichuan Friendly Pharmaceutical Co., LTD, Production Address: No. 680, Hongpai Road, Dongxing District, Neijiang City Sichuan, China Tel:+886 832 2240082/2240298, NDC 7807-0170-11", "report_date": "20181017", "classification": "Class II", "openfda": {}, "recalling_firm": "Alkano Chemicals, Inc", "recall_number": "D-0008-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81147", "termination_date": "20190221", "more_code_info": "", "recall_initiation_date": "20180830", "postal_code": "91203-1439", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93710", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0280-2024", "product_description": "PHENYLephrine HCl 40 mg per 250 mL 0.9% Sodium Chloride (160 mcg per mL), Item F3352, for IV use only; Leiters 13796 Compark Blvd Englewood, CO 80112; NDC 71449-150-82.", "product_quantity": "12,564 IV bags", "reason_for_recall": "Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.", "recall_initiation_date": "20231228", "center_classification_date": "20240129", "report_date": "20240207", "code_info": "Lot #: 2330939, Exp. Date 01/30/2024; 2331032, Exp. Date 02/03/2024; 2331112, Exp. Date 03/19/2024; 2331190, Exp. Date 03/26/2024; 2331429, Exp. Date 04/28/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-945-2015", "product_description": "Trimeprazine Tartrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "6778 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077908"], "brand_name": ["PROPOFOL"], "generic_name": ["PROPOFOL"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4699", "0409-6010"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PROPOFOL"], "rxcui": ["1808217", "1808222", "1808224"], "spl_id": ["d55c0318-811d-4624-aa0c-456182f7b019"], "spl_set_id": ["28d7ba00-f824-4e55-139a-03f509c099db"], "package_ndc": ["0409-4699-50", "0409-4699-30", "0409-4699-53", "0409-4699-33", "0409-4699-54", "0409-4699-24", "0409-6010-02", "0409-6010-25"], "is_original_packager": [true], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["YI7VU623SF"]}, "product_type": "Drugs", "event_id": "70179", "recalling_firm": "Hospira Inc.", "address_1": "375 N Field Dr", "address_2": "N/A", "postal_code": "60045-2513", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0381-2015", "product_description": "Propofol Injectable Emulsion, 1%, 200 mg/20 mL, (10mg/mL), 20 mL, Single patient infusion vial, Contains Benzyl Alcohol, For I.V. Administration, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30", "product_quantity": "126,075 vials", "reason_for_recall": "Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron.", "recall_initiation_date": "20141223", "center_classification_date": "20150127", "termination_date": "20150730", "report_date": "20150204", "code_info": "Lot 35-844-DJ, Exp 11/01/2015"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0696-2020", "product_description": "BUP 23MG/HYDROM 25MG/SUF 100MCG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@15 Exp. 12/25/2019", "more_code_info": ""}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "B5007 Exp 8/7/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Progesterone 100 mg/ml in Olive Oil Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-776-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Tulsa", "address_1": "6136 E 51st St", "reason_for_recall": "Lack of Assurance of Sterility: concerns of sterility assurance with the  pharmacy's independent testing laboratory", "address_2": "", "product_quantity": "1,430 mL", "code_info": "Lot #s: 05132013@25, Exp 11/9/13; 08072013@4, Exp 2/3/14", "center_classification_date": "20131003", "distribution_pattern": "Oklahoma", "state": "OK", "product_description": "SIH-Testosterone Cypionate 200 mg/mL Injectable, 10 mL sterile vial, The Apothecary Shoppe, 6136 E. 51st St. Tulsa, OK 74135.", "report_date": "20131009", "classification": "Class II", "openfda": {}, "recalling_firm": "Apothecary Shoppe", "recall_number": "D-66241-002", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66241", "termination_date": "20160208", "more_code_info": "", "recall_initiation_date": "20130906", "postal_code": "74135-7704", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Whippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88677", "recalling_firm": "Bayer Healthcare Pharmaceuticals Inc.", "address_1": "100 Bayer Blvd", "address_2": "N/A", "postal_code": "07981-1544", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.", "recall_number": "D-0237-2022", "product_description": "LOTRIMIN AF (Miconazole nitrate 2%) Jock Itch Powder Spray NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain,  NDC 11523-4140-2. UPC 3 11017 41031 8", "product_quantity": "4,546,152 cans", "reason_for_recall": "cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.", "recall_initiation_date": "20211001", "center_classification_date": "20211118", "termination_date": "20230626", "report_date": "20211124", "code_info": "Lot #:  CV01BEP, 3/31/2022; CV01D6W, 5/31/2022; CV01EV0, 7/31/2022; TN0004J, 9/30/2022; TN001AE, 11/30/2022; TN003C3, 1/31/2023; TN003C4, 2/28/2023; TN003HT, 3/31/2023; TN003CW, 4/30/2023; TN0045J, 6/30/2023; TN0040C, 7/31/2023; TN004BU, 8/31/2023; TN006MB, 9/30/2022;", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73899", "recalling_firm": "Baptist Health Medical Towers Pharmacy and Infusion Services", "address_1": "9601 Baptist Health Dr Ste 109", "address_2": "N/A", "postal_code": "72205-6323", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Arkansas", "recall_number": "D-0930-2016", "product_description": "Milrinone 200 mcg/mL in  a) D5W-300 mL, b) D5W-400 mL, c) D5W-500 mL and d) D5W-600 mL Bags, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR", "product_quantity": "a) 15 bags, b) 15 bags, c) 15 bags, d) 4 bags", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20160418", "center_classification_date": "20160529", "termination_date": "20161223", "report_date": "20160608", "code_info": "All product remaining within expiry"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208411"], "brand_name": ["NARCAN"], "generic_name": ["NALOXONE HYDROCHLORIDE"], "manufacturer_name": ["Emergent Devices Inc."], "product_ndc": ["69547-212", "69547-353"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["NALOXONE HYDROCHLORIDE"], "rxcui": ["1725059", "1725064", "1870933", "1870935"], "spl_id": ["1d0be895-cd43-49f3-98d4-72a9c3088616"], "spl_set_id": ["724df050-5332-4d0a-9a5f-17bf08a547e1"], "package_ndc": ["69547-212-04", "69547-212-24", "69547-353-02"], "is_original_packager": [true], "unii": ["F850569PQR"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0473-2021", "product_description": "Narcan (naloxone HCl) Nasal Spray 4 mg Two Pack This box contains two (2) 4-mg doses of naloxone HCl in 0.1 mL of nasal spray. 0.1 mL intranasal spray per unit For use in the nose only Rx only NDC 69547-353-02 Distributed by Adapt Pharma, Inc. Radnor, PA 19087 USA", "product_quantity": "11189 plungers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "201701"}, {"status": "Terminated", "city": "Tlalnepantla", "state": "N/A", "country": "Mexico", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86037", "recalling_firm": "AAA Cosmetica, SA de CV", "address_1": "Calle Recursos Hidraulicos 1", "address_2": "Pueblo La Loma, Tlalnepantla De Baz", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1570-2020", "product_description": "bio aaa Advance Hand Sanitizer Ethyl Alcohol 70%, Unscented, 16.23 Oz (480 mL), Distributed By: Payless Janitorial Corporation 1341 SW 21 Terrance, Fort Lauderdale, Florida  Exported By: E. Audicode S.A. de C.V. Manufactured By: AAA Cosmetica S.A. de C.V.  UPC  7 502272 12111 5", "product_quantity": "204,768 bottles", "reason_for_recall": "Chemical Contamination: Product contains methanol.", "recall_initiation_date": "20200702", "center_classification_date": "20200911", "termination_date": "20240116", "report_date": "20200909", "code_info": "Lots: 20DF9001, 20DF9002, 20DF9003, 20DF9004, 20DF9007, 20DF9008, 20DF9009, 20DF9010, 20DF9011, 20DF9012, 20DF9013, 20DF9014, 20DF9015, 20DF9016, 20DF9017, 20DF9018, 20DF9019, 20DF9020, 20DF9021, 20DF9022, EXP April 2022"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA211913"], "brand_name": ["ABSORICA LD"], "generic_name": ["ISOTRETINOIN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["10631-002", "10631-115", "10631-116", "10631-117", "10631-118", "10631-133", "10631-134", "10631-003", "10631-004", "10631-005", "10631-006", "10631-007"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ISOTRETINOIN"], "rxcui": ["197843", "197844", "197845", "403930", "1299203", "1300006", "1300014", "1300016", "1547561", "1547563", "1547565", "1547567", "2262711", "2262713", "2262714", "2262715", "2262717", "2262719", "2262721", "2262723", "2262725", "2262727", "2262729", "2262731"], "spl_id": ["fba81535-0761-42a7-b422-338f8bd2cfc6"], "spl_set_id": ["3ef0cff8-19c1-4441-b780-fca6c7ee1615"], "package_ndc": ["10631-115-69", "10631-115-31", "10631-116-69", "10631-116-31", "10631-117-69", "10631-117-31", "10631-118-69", "10631-118-31", "10631-133-69", "10631-133-31", "10631-134-69", "10631-134-31", "10631-002-31", "10631-003-31", "10631-004-31", "10631-005-31", "10631-006-31", "10631-007-31"], "is_original_packager": [true], "nui": ["N0000175607", "M0018962"], "pharm_class_epc": ["Retinoid [EPC]"], "pharm_class_cs": ["Retinoids [CS]"], "unii": ["EH28UP18IF"]}, "product_type": "Drugs", "event_id": "71865", "recalling_firm": "Ranbaxy Inc.", "address_1": "600 College Rd E Ste 2100", "address_2": "N/A", "postal_code": "08540-6636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1288-2015", "product_description": "Absorica (isotretinoin) Capsules, 25 mg, Packaged in 3 x 10 Count Blister Cards/Box, Rx Only.  Manufactured for: RANBAXY LABORATORIES, INC Jacksonville, FL 32257 USA. NDC: 10631-133-31.", "product_quantity": "9,229 Boxes", "reason_for_recall": "Incorrect/Undeclared Excipients: Product contains undeclared FD&C Yellow No. 5 in the capsule shell.", "recall_initiation_date": "20150626", "center_classification_date": "20150806", "termination_date": "20160429", "report_date": "20150812", "code_info": "Lot #:14H04AA, Expiry: 02/28/2017."}, {"status": "Terminated", "city": "Albany", "state": "OR", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "89152", "recalling_firm": "Dental Alliance Holdings LLC", "address_1": "812 Water Ave Ne", "address_2": "", "postal_code": "97321-3074", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide with the United States", "recall_number": "D-0457-2022", "product_description": "CTx36 Kit, contains three tubes of CariFree CTx4 Gel 5000, 1.1% Neutral Sodium Fluoride Mint, 2 oz (57 g) Rx only NDC: 61578-205-01 Manufactured by Oral BioTech Albany, Oregon 97321 and six boxes of 4fl.oz. Carifree CTx4 Treatment Rinse.", "product_quantity": "90 single tubes of 352110 and 315 single tubes of 352111", "reason_for_recall": "Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.", "recall_initiation_date": "20211203", "center_classification_date": "20220126", "termination_date": "20220811", "report_date": "20220202", "code_info": "Lot #: 352110, 352111 Exp. Date 06/22;  (contains recalled CariFree CTx4 5000 gel tube lot 142017)", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077912"], "brand_name": ["LISINOPRIL AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LISINOPRIL AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-518", "68180-519", "68180-520"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LISINOPRIL"], "rxcui": ["197885", "197886", "197887"], "spl_id": ["1474b42e-df82-41d5-9cbd-ebe3c45dcc9d"], "spl_set_id": ["515f735c-5dba-43d9-8a58-97a319cafd56"], "package_ndc": ["68180-518-02", "68180-518-01", "68180-518-30", "68180-519-30", "68180-519-01", "68180-519-02", "68180-520-02", "68180-520-30", "68180-520-01"], "is_original_packager": [true], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "E7199S1YWR"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0188-2024", "product_description": "Lisinopril and Hydrochlorothiazide Tablets USP, 10mg/12.5mg, Rx only, 100 Tablets per bottles, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Nagpur-441 108, India.  NDC:   68180-518-01", "product_quantity": "2 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch Q101699, Q101981", "more_code_info": ""}, {"status": "Ongoing", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["42292-038", "42292-039", "42292-041", "42292-040"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["966248", "966249", "966253", "966270"], "spl_id": ["3a991bf1-d9aa-b137-e063-6294a90af2cf"], "spl_set_id": ["cd69c192-cd3f-47e6-b0a6-c536ffed5c4b"], "package_ndc": ["42292-038-01", "42292-038-20", "42292-039-01", "42292-039-20", "42292-041-01", "42292-041-20", "42292-040-01", "42292-040-20"], "original_packager_product_ndc": ["0378-1807", "0378-1811", "0378-1823", "0378-1817"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95817", "recalling_firm": "Mylan Institutional, Inc.", "address_1": "1718 Northrock Ct", "address_2": "", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0134-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.  NDC: 42292-041-20", "product_quantity": "1,133 cartons", "reason_for_recall": "Subpotent and Superpotent Drug", "recall_initiation_date": "20241119", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: 3115448, Exp. Date 12/31/2024;3115732, Exp. Date  3/31/2025;  3116024, Exp. Date 9/30/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Long Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73304", "recalling_firm": "Hartley Medical Center Pharmacy, Incorporated", "address_1": "113 W Victoria St", "address_2": "N/A", "postal_code": "90805-2162", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide. No foreign distribution.", "recall_number": "D-0762-2016", "product_description": "Morphine Sulfate 20 mg/ml, vol. 42 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160204", "center_classification_date": "20160304", "termination_date": "20160809", "report_date": "20160316", "code_info": "BUD: 5/3/2016"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-652-2015", "product_description": "Estradiol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "4031 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Felt", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82106", "recalling_firm": "McDaniel Life-Line LLC", "address_1": "Hc 1 Box 2b", "address_2": "N/A", "postal_code": "73937-9703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide, Italy, Australia, Canada, Poland", "recall_number": "D-1111-2019", "product_description": "Indian Herb Paste (a dietary supplement) Ingredients: Galangal, Indian Paint, Yellow Dock & Licorice in an alloy of Life-Line tm and Zinc Chloride in 6 dram vials, McDaniel Life-Line LLC, Dimmitt, TX", "product_quantity": "150 vials", "reason_for_recall": "Unapproved new drug", "recall_initiation_date": "20190208", "center_classification_date": "20190409", "termination_date": "20201215", "report_date": "20190417", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA209482"], "brand_name": ["TRELEGY ELLIPTA"], "generic_name": ["FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0887", "0173-0893"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["FLUTICASONE FUROATE", "UMECLIDINIUM BROMIDE", "VILANTEROL TRIFENATATE"], "rxcui": ["1945039", "1945044", "1945047", "1945048", "2395769", "2395771", "2395774", "2395775"], "spl_id": ["676a0120-5f94-4470-b936-2c8cfb32d3fc"], "spl_set_id": ["b5a81d5a-4648-4c7a-951d-33c014a63c7e"], "package_ndc": ["0173-0887-10", "0173-0887-14", "0173-0887-61", "0173-0893-10", "0173-0893-14", "0173-0893-61"], "is_original_packager": [true], "unii": ["40AHO2C6DG", "7AN603V4JV", "JS86977WNV"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0482-2021", "product_description": "Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) 100 mcg/62.5 mcg/25 mcg; 1 ELLIPTA Inhaler containing 30 doses (60 blisters total) Rx Only NDC 0173-0887-10 GlaxoSmithKline Research Triangle Park, NC 27709", "product_quantity": "903 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3X8P"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73899", "recalling_firm": "Baptist Health Medical Towers Pharmacy and Infusion Services", "address_1": "9601 Baptist Health Dr Ste 109", "address_2": "N/A", "postal_code": "72205-6323", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Arkansas", "recall_number": "D-0922-2016", "product_description": "Deferoxamine 2 grams/51 mL NS cassette, FOR SUBCUTANEOUS USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR", "product_quantity": "5 cassettes", "reason_for_recall": "Lack of Sterility Assurance.", "recall_initiation_date": "20160418", "center_classification_date": "20160529", "termination_date": "20161223", "report_date": "20160608", "code_info": "All product remaining within expiry."}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-298-2014", "product_description": "Testosterone Pellet 87.5mg, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "24 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1548-2019", "product_description": "TOOTSIE ROLL FRUIT CHEWS LEMON SCENTED ANTIBACTERIAL HAND GEL (Ethyl Alcohol 62%), 1.35 fl oz / 40 mL, OTC, Distributed by: JFL Enterprises, Inc. Cleveland, Ohio 44102.", "product_quantity": "8,856", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20181112, Exp 11/11/2020"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0807-2022", "product_description": "SB-5, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . PGE 50 mcg/mL, 10 mL, Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0024-10.", "product_quantity": "1110 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: E48B18 BUD: 5/18/2022, E48D18 BUD; 5/18/2022, H24D31 BUD: 8/31/2022; E48C18 BUD: 5/18/2022", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "44 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  02232015@22, 5/24/2015; 03202015@81, 6/18/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 70 mg/ml + Clonidine 1,100 mcg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1615-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "1650 ml", "code_info": "All lots distributed between November 2014 and May 2015;  03022015@68, 5/31/2015; 04102015@4, 7/9/2015; 04242015@23, 7/23/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "LIPO-DEN MODIFIED Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1685-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021395"], "brand_name": ["SPIRIVA"], "generic_name": ["TIOTROPIUM BROMIDE"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0075"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL", "RESPIRATORY (INHALATION)"], "substance_name": ["TIOTROPIUM BROMIDE MONOHYDRATE"], "rxcui": ["485032", "580261"], "spl_id": ["902426f3-c843-416d-a1e3-b64eafc1f32d"], "spl_set_id": ["820839ef-e53d-47e8-a3b9-d911ff92e6a9"], "package_ndc": ["0597-0075-41", "0597-0075-75", "0597-0075-47", "0597-0075-27"], "is_original_packager": [true], "unii": ["L64SXO195N"]}, "product_type": "Drugs", "event_id": "65428", "recalling_firm": "Boehringer Ingelheim Roxane Inc", "address_1": "1809 Wilson Rd", "address_2": "N/A", "postal_code": "43228-9579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1057-2013", "product_description": "SPIRIVA HandiHaler (Tiotropium Bromide Inhalation Powder) Capsules 18 mcg per dose, Rx only, a) 10 count blister (NDC 0597-0075-27), b) 30 count blister (NDC 0597-0075-41), c) 90 count blister (NDC 0597-0075-47), d) 5 count blister physician sample (NDC 0597-0075-75), Manufactured by: Boehringer Ingelheim (BI) Pharma, GmbH & Co. KG, Ingelheim, Germany", "product_quantity": "15,385,232 capsules", "reason_for_recall": "Presence of Foreign Substance: This recall is being conducted due to the potential for extrinsic foreign particles in the API used to manufacture SPIRIVA Handihaler", "recall_initiation_date": "20130830", "center_classification_date": "20130916", "termination_date": "20140616", "report_date": "20130925", "code_info": "Lot Number/Exp. Date:   202477A/Sep-13, 202480A/Sep-13, 202556B/Sep-13, 202603A/Sep-13, 202784B/Sep-13, 202844A/Sep-13, 202951A/Sep-13, 203041A/Sep-13,  203042A,Sep-13, 203280A/Oct-13, 203281A/Oct-13, 203364A/Oct-13,  203440A,Oct-13, 203569B/Oct-13, 203588A/Oct-13, 203890B/Nov-13,  204094A/Nov-13, 203660A/Nov-13, 203690A/Nov-13, 203890A/Nov-13,  203980A/Nov-13, 203981B/Nov-13, 204356B/Dec-13, 204357A/Dec-13,  204821A/Dec-13, 204459A/Dec-13, 204552C/Dec-13, 204822A/Dec-13,  204944A/Jan-14, 204947A/Jan-14, 205015A/Jan-14, 205163A/Jan-14,   205364A/Jan-14, 205509A/Feb-14, 205737A/Feb-14, 205571A/Feb-14,  205572A/Feb-14, 205674A/Feb-14, 205682A/Feb-14, 205959A/Feb-14,  205987A/Feb-14, 206186B/Mar-14, 206311A/Mar-14, 206606A/Mar-14,  206944B/Apr-14, 207066A/Apr-14, 206609A/Apr-14, 206729A/Apr-14,  206899A/Apr-14, 206900A/ Apr-14, 207065B/Apr-14, 207191A/May-14,  207199A/May-14, 207352A/May-14, 207420A/May-14, 207577B/May-14,  207691A/May-14, 207692A/May-14, 207778A/May-14, 207818A/Jun-14,  301378A/Jul-14, 301476B/Jul-14, 301699B/Jul-14, 301867A/Aug-14,  202530/Sep-13, 203195A/Oct-13, 203366C/Nov-13, 204067A/Nov-13,  204460B/Dec-13, 204551A/Dec-13, 205260A/Jan-14, 206064B/Mar-14,  206185A/Mar-14, 206939A/Apr-14, 207038A/May-14, 301699A/Jul-14,  202556A/Sep-13, 203569A/Oct-13, 203981A/Nov-13, 204674A/Dec-13,  205737B/Feb-14, 206944A/Apr-14, 207577A/May-14, 301476A/Jul-14  Physician Drug Samples:   203076A/Oct-13, 203891A/Nov-13, 204674B/Dec-13, 205867A/Feb-14,  206731A/Apr-14", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206530"], "brand_name": ["FAMOTIDINE"], "generic_name": ["FAMOTIDINE"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-859", "65862-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FAMOTIDINE"], "rxcui": ["284245", "310273"], "spl_id": ["e0c726f6-8257-4dba-b2f9-d78d28097bd9"], "spl_set_id": ["b0798337-1a73-415e-8416-613984ce5c65"], "package_ndc": ["65862-859-30", "65862-859-01", "65862-859-05", "65862-859-99", "65862-859-10", "65862-859-78", "65862-860-30", "65862-860-01", "65862-860-05", "65862-860-99", "65862-860-10", "65862-860-78"], "is_original_packager": [true], "nui": ["N0000000151", "N0000175784"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "unii": ["5QZO15J2Z8"]}, "product_type": "Drugs", "event_id": "87193", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX, CA, GA, PA", "recall_number": "D-0290-2021", "product_description": "Famotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India, NDC 65862-860-99", "product_quantity": "1296 bottles", "reason_for_recall": "Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.", "recall_initiation_date": "20210120", "center_classification_date": "20210226", "termination_date": "20231012", "report_date": "20210310", "code_info": "Lot #: P2000467, Exp 7/2022", "more_code_info": ""}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2000 mL in Vials", "code_info": "a) Lot #: 160126-20, BUD: 07/24/16.  b) Lot #: 160126-20, BUD: 07/24/16.", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "PYRIDOXINE HCL 100MG/ML (PF), In a) 2ML Vials and b) 5ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1235-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "La Jolla", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86125", "recalling_firm": "RESOURCE RECOVERY & TRADING LLC", "address_1": "4275 Executive Sq Ste 200", "address_2": "N/A", "postal_code": "92037-1476", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "AL, GA", "recall_number": "D-1548-2020", "product_description": "Hand Sanitizer Disinfectant Gel 70% Ethyl Alcohol, packaged in 6.7 FL Oz. (200 mL) bottles, Distributed by: Access USA, Miami, FL 33308, UPC 650240025020", "product_quantity": "17,280 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20200727", "center_classification_date": "20200827", "report_date": "20200902", "code_info": "All lots."}, {"status": "Terminated", "city": "Henderson", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80343", "recalling_firm": "Gaia Ethnobotanical LLC", "address_1": "2752 Botticelli Dr", "address_2": "", "postal_code": "89052-3107", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-0995-2018", "product_description": "Gaia Kratom (mitragyna speciosa) powder, Ganesh, 1oz, 250g, 1kg packages, Gaia Ethnobotanical.com", "product_quantity": "unknown", "reason_for_recall": "Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination", "recall_initiation_date": "20180620", "center_classification_date": "20180726", "termination_date": "20220126", "report_date": "20180718", "code_info": "Lot # 0102031800", "more_code_info": ""}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "3 vials", "code_info": "Lot # t12-28-2016@113, Exp 6/27/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "5-MTHF 10ML SDV (CALIF) 5MG/ML INJ, Injection 5mg/mL, Rx only, 10mL Glass /Single Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0709-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206751"], "brand_name": ["METHYLPREDNISOLONE"], "generic_name": ["METHYLPREDNISOLONE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-916", "68382-917", "68382-918", "68382-919"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPREDNISOLONE"], "rxcui": ["197971", "197973", "259966", "328161", "762675"], "spl_id": ["e7c45905-daf8-4deb-bfa0-b2afe021a18a"], "spl_set_id": ["eaa9c932-c659-4ef6-bf5a-186545d87320"], "package_ndc": ["68382-916-01", "68382-916-05", "68382-916-34", "68382-917-11", "68382-917-01", "68382-917-05", "68382-917-30", "68382-917-77", "68382-918-18", "68382-918-01", "68382-918-05", "68382-918-30", "68382-918-77", "68382-919-11", "68382-919-01", "68382-919-05", "68382-919-30", "68382-919-77"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["X4W7ZR7023"]}, "product_type": "Drugs", "event_id": "82827", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1450-2019", "product_description": "MethylPREDNISolone Tablets, USP 16 mg, 50 tablets, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India  NDC 68382-918-18", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.", "recall_initiation_date": "20190506", "center_classification_date": "20190701", "termination_date": "20210916", "report_date": "20190626", "code_info": "lots: M713034, M713035, M713036, EXP Nov-19; M814747 Sep-20; M819266, EXP Dec-20"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0783-2019", "product_description": "Dr. King's SafeCare Rx Aller-Detox: Food Addititives & Preservatives, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955240525, NDC 57955-2405-2", "product_quantity": "96 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 030916N Exp. 03/19; 121217A Exp. 12/19"}, {"status": "Terminated", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "65196", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-835-2013", "product_description": "Piperacillin and Tazobactam for Injection, USP, 40.5 grams per Pharmacy Bulk Package vial, Rx only, Mfg. by: Hospira Healthcare India Pvt. Ltd., Irungattukottai - 602 105, India; Mfg. for: Apotex Corp., Weston, FL 33326, NDC 60505-0773-0", "product_quantity": "52,398 vials", "reason_for_recall": "Crystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.", "recall_initiation_date": "20130510", "center_classification_date": "20130802", "termination_date": "20180108", "report_date": "20130814", "code_info": "Lot No. 503B023, Exp. 08/13; 503B028, 503B029, 503B030, 503B031, 503B032, 503B033, Exp. 11/13; 503C001, 503C002, 503C003, 503C004, Exp. 12/13; 503C009, Exp. 01/14; 503C010, 503C011, 503C012, 503C014, Exp. 02/14; 503C015, 503C016, 503C017, 503C019, 503C020, Exp. 04/14"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0664-2019", "product_description": "Dr. King's Natural Medicine for kids! Children's Cough Relief Homeopathic, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside dr. Asheville, NC 28806 USA, UPC 357955514527, NDC 57955-6145-2", "product_quantity": "1010 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 021216J Exp. 02/2019; 030916T Exp. 03/2019; 092815E Exp. 09/2018"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020832"], "brand_name": ["CHLORAPREP ONE-STEP"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["CareFusion 213, LLC"], "product_ndc": ["54365-400"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["858726", "998282"], "spl_id": ["42641d19-c870-7770-e063-6294a90acf97"], "spl_set_id": ["8529596f-37e4-c44e-e053-2a91aa0ad014"], "package_ndc": ["54365-400-32"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "87592", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA and to Singapore, Chile, Oman, Columbia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, Brazil.", "recall_number": "D-0343-2021", "product_description": "BD ChloraPrep Clear, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Sterile Solution, 0.10 fl. oz. (3 ml) each, 25 Applicators in carton, applicator is sterile if package is intact. CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co, NDC 54365-400-32 REF 930400", "product_quantity": "952,100 cartons", "reason_for_recall": "Non-sterility.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity.", "recall_initiation_date": "20210319", "center_classification_date": "20210426", "termination_date": "20220929", "report_date": "20210505", "code_info": "Lot and Exp Date:  0065386, 2/28/2023;  0085419, 3/31/2023;  0091666, 3/31/2023;  0149328, 4/30/2023;  0151977, 5/31/2023;  0161217, 5/31/2023;  0175874, 6/30/2023;  0176660, 6/30/2023;  0188805, 6/30/2023;  0211068, 7/31/2023;", "more_code_info": ""}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA206535"], "brand_name": ["ACYCLOVIR"], "generic_name": ["ACYCLOVIR"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "product_ndc": ["68382-048", "68382-049"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ACYCLOVIR SODIUM"], "rxcui": ["1734932", "1734934"], "spl_id": ["515388e8-636f-42f6-a39e-bb4fc7c2e7cb"], "spl_set_id": ["69a98000-adef-4323-89a7-09e035a257d4"], "package_ndc": ["68382-048-01", "68382-048-10", "68382-049-01", "68382-049-10"], "is_original_packager": [true], "unii": ["927L42J563"]}, "product_type": "Drugs", "event_id": "87364", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0315-2021", "product_description": "Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 20mL Single-Dose Vials per pack NDC 68382-049-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India. Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.", "product_quantity": "816  packs", "reason_for_recall": "Crystallization: customer complaints for crystallization in finished product.", "recall_initiation_date": "20210218", "center_classification_date": "20210330", "termination_date": "20221123", "report_date": "20210407", "code_info": "Lot#: L000155, Exp 12/2021; L000156, Exp 1/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0629-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Adrenal Burnout, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955597926, NDC 57955-1434-2", "product_quantity": "4888 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 050218E Exp. 05/20; 080317E Exp. 08/19; 120216A Exp. 12/19; 120217F Exp. 12/19"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-836-2015", "product_description": "Pentosan Polysulfate Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "36955 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup;  PHYTONADIONE Tablet, 5 mg may be potentially mislabeled as    medroxyPROGESTERone ACETATE, Tablet, 10 mg, NDC 59762374202, Pedigree: AD46312_19, EXP: 5/16/2014;  HYDROCORTISONE, Tablet, 5 mg, NDC 00603389919, Pedigree: W003060, EXP: 6/12/2014;  GALANTAMINE HBR ER, Capsule, 24 mg, NDC 47335083783, Pedigree: W003735, EXP: 5/31/2014;  TORSEMIDE, Tablet, 10 mg, NDC 31722053001,", "address_2": "", "product_quantity": "500 Tablets", "code_info": "PHYTONADIONE Tablet, 5 mg has the following codes    Pedigree: AD46312_22, EXP: 4/30/2014;  Pedigree: W003061, EXP: 5/31/2014;  Pedigree: W003737, EXP: 5/31/2014;  Pedigree: AD25452_1, EXP: 4/30/2014;  Pedigree: W003440, EXP: 5/31/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PHYTONADIONE Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 25010040515", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-541-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-507-2013", "product_description": "AMBI 12.5 CPD/120GFN/5PEH, Cough Suppressant,  Expectorant,  Nasal Decongestant,  Berry Vanilla Flavor, 16 fl oz. bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0224-16", "product_quantity": "348 - 16 ounce bottles", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot # 12HQ006, Exp. 07/14."}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065053"], "brand_name": ["DOXYCYCLINE"], "generic_name": ["DOXYCYCLINE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["63304-614", "63304-615", "63304-616"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXYCYCLINE"], "rxcui": ["700408", "1649401", "1649990"], "spl_id": ["338488d1-e9d8-6b00-e063-6294a90a37c0"], "spl_set_id": ["829dbd3d-5c2b-47b8-96a5-423af78c93b9"], "package_ndc": ["63304-614-20", "63304-614-05", "63304-614-01", "63304-614-13", "63304-615-05", "63304-615-11", "63304-615-01", "63304-616-20", "63304-616-05", "63304-616-01", "63304-616-13", "63304-616-50"], "is_original_packager": [true], "upc": ["0363304614015"], "nui": ["N0000175882", "N0000007948"], "pharm_class_epc": ["Tetracycline-class Drug [EPC]"], "pharm_class_cs": ["Tetracyclines [Chemical/Ingredient]"], "unii": ["N12000U13O"]}, "product_type": "Drugs", "event_id": "85230", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1032-2020", "product_description": "Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.", "product_quantity": "624 bottles", "reason_for_recall": "CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.", "recall_initiation_date": "20200313", "center_classification_date": "20200318", "termination_date": "20210209", "report_date": "20200325", "code_info": "Lot #: AA39490, Exp 03/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA212721"], "brand_name": ["CEFEPIME HYDROCHLORIDE"], "generic_name": ["CEFEPIME HYDROCHLORIDE"], "manufacturer_name": ["Xellia Pharmaceuticals USA LLC"], "product_ndc": ["70594-089", "70594-090"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["CEFEPIME HYDROCHLORIDE"], "rxcui": ["1665088", "1665093"], "spl_id": ["c95e6247-9ce3-4376-b394-ac8c8009f495"], "spl_set_id": ["91f72dcf-eb1f-4fc6-b9a2-042424012e3e"], "package_ndc": ["70594-089-01", "70594-089-02", "70594-090-01", "70594-090-02"], "is_original_packager": [true], "unii": ["I8X1O0607P"]}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0609-2023", "product_description": "Cefepime for Injection, USP 1 gram per vial, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-089-02", "product_quantity": "550,160 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "71601", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Including: CA, IL, LA, OH, PA, and SC.", "recall_number": "D-1831-2015", "product_description": "METOCLOPRAMIDE ORAL SOLUTION, USP 10 mg/10 mL, 10 mL cups, Rx only. Manufactured by VistaPharm, Inc, Largo, FL. NDC: 66689-031-01.", "product_quantity": "84,100 Cups", "reason_for_recall": "Defective Container: Lids on unit dose cups are not fully qualified.", "recall_initiation_date": "20150626", "center_classification_date": "20150928", "termination_date": "20170214", "report_date": "20151007", "code_info": "Lot #: 387500, Expiry: 01/17"}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA090583"], "brand_name": ["AMPICILLIN"], "generic_name": ["AMPICILLIN SODIUM"], "manufacturer_name": ["Xellia Pharmaceuticals USA LLC"], "product_ndc": ["70594-084", "70594-085", "70594-086", "70594-087"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["AMPICILLIN SODIUM"], "rxcui": ["1721473", "1721474", "1721475", "1721476"], "spl_id": ["03c0f1f1-0132-46ee-a71c-f5e77bd6131e"], "spl_set_id": ["94421dac-7865-49f8-ae52-871eee6465ac"], "package_ndc": ["70594-084-01", "70594-084-02", "70594-085-01", "70594-085-02", "70594-086-01", "70594-086-02", "70594-087-01", "70594-087-02"], "is_original_packager": [true], "unii": ["JFN36L5S8K"]}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0588-2023", "product_description": "Ampicillin for Injection, USP 2 g per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-087-02", "product_quantity": "220,340 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91450", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0099-2023", "product_description": "Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), 5 x 5 mL Pre-Filled Syringe, 6 x 5 syringe carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th Street Extension, West Columbia, SC 29172, NDC: 69374-924-05", "product_quantity": "38,830 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230106", "center_classification_date": "20230109", "termination_date": "20240924", "report_date": "20230118", "code_info": "Lot: RC2011A, Exp. 2/22/2023", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "5 ml", "code_info": "All lots distributed between November 2014 and May 2015;    05052015@20, 11/3/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Tri-Mix T-102 (17.65 mg/0.59 mg/10 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1804-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "71973", "recalling_firm": "Ohm Laboratories, Inc.", "address_1": "1385 Livingston Ave", "address_2": "N/A", "postal_code": "08902-1829", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0038-2016", "product_description": "Wal-itin Loratadine Orally Disintegrating Tablets, USP, 10 mg, packaged in a) 10-coiunt tablets per box, (NDC 0363-0527-69, ITEM 367492,UPC 3 1191717021 3); and b) 30-count tablets per box, (NDC 0363-0527-31, ITEM 254166, UPC 3 191715562 ) Distributed by Walgreen Co., 200 Wilmot Road, Deerfield, IL  60015", "product_quantity": "329,748 boxes", "reason_for_recall": "Superpotent Drug: Out Of Specification (OOS) result for Assay.", "recall_initiation_date": "20150728", "center_classification_date": "20151015", "termination_date": "20161028", "report_date": "20151021", "code_info": "Batch Numbers:  a) 2625093, Exp 6/30/2016; 2617893, Exp 5/31/2016; 2658137, 2658140,  Exp 11/30/2016; 2644265, Exp 9/30/2016    b) 2544486, 2544487, 2544488, Exp 7/31/2016; 2600125, 2600126, 2600127, Exp  2/29/2016; 2644272, 2644273, 2644265, Exp 9/30/2016; 2625092, 2625093, Exp 6/30/2016; 2658137, 2658138, 2658140  Exp 11/30/2016; 2610783, Exp 4/30/2016;   2617891, Exp 5/31/2016."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: CETIRIZINE HCL, Tablet, 5 mg may have potentially been mislabeled as the following drug:  LITHIUM CARBONATE ER, Tablet, 300 mg, NDC 00054002125, Pedigree: AD39564_1, EXP: 5/13/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "CETIRIZINE HCL, Tablet, 5 mg has the following codes:   Pedigree: AD32757_13, EXP: 5/13/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CETIRIZINE HCL, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378363501.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-906-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207372"], "brand_name": ["NITROFURANTOIN"], "generic_name": ["NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-625"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NITROFURANTOIN", "NITROFURANTOIN MONOHYDRATE"], "rxcui": ["1648755"], "spl_id": ["0e77340b-340d-fe13-e063-6294a90a0301"], "spl_set_id": ["736b2487-e83f-d172-e053-2a91aa0ab0cf"], "package_ndc": ["50268-625-11", "50268-625-15"], "original_packager_product_ndc": ["65162-478"], "nui": ["N0000175494", "M0014892"], "pharm_class_epc": ["Nitrofuran Antibacterial [EPC]"], "pharm_class_cs": ["Nitrofurans [CS]"], "unii": ["927AH8112L", "E1QI2CQQ1I"]}, "product_type": "Drugs", "event_id": "95919", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0168-2025", "product_description": "Nitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478.  NDC#: 50268-625-15.", "product_quantity": "1016 50-count cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20241204", "center_classification_date": "20241231", "report_date": "20250108", "code_info": "Lot # 47101; Exp. 02/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73822", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0841-2016", "product_description": "Ondansetron Tablets USP, 4 mg, 30 count bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories, Bachupally, India --- NDC 56111-153-30", "product_quantity": "50,280 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications; 12 month stability time point", "recall_initiation_date": "20160330", "center_classification_date": "20160509", "termination_date": "20170410", "report_date": "20160518", "code_info": "Lot number C500691, exp 12/2016"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0542-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Gallbladder Formula, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955506829, NDC 57955-6058-2", "product_quantity": "1735 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 031017K Exp. 03/20; 040616E Exp. 04/19; 060216F Exp. 06/19"}, {"status": "Terminated", "city": "Morristown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77484", "recalling_firm": "Bayer HealthCare Pharmaceuticals, Inc.", "address_1": "36 Columbia Rd", "address_2": "N/A", "postal_code": "07960-4526", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1050-2017", "product_description": "Alka-Seltzer Extra Strength (500 mg Aspirin (NSAID), 1985 mg Analgesic Sodium bicarbonate/Antacid, 1000 mg Anhydrous Citric Acid) Effervescent Tablets, 24-count carton, Made in Germany, Distributed by Bayer HealthCare, LLC Whippany, NJ 07981,  UPC 016500044048", "product_quantity": "24,672 24-count cartons", "reason_for_recall": "Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.", "recall_initiation_date": "20170330", "center_classification_date": "20170801", "termination_date": "20200108", "report_date": "20170809", "code_info": "BTAHDG0; Exp. 04/19"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0548-2017", "product_description": "HYDROQUINONE SOLUTION  in all strengths including 4%, 28%,  Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0681-2019", "product_description": "Dr. King's SafeCare Rx Colic Relief Children High Potency Homeopathic Formula for Professional Use Only, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955015826, NDC 57955-0178-2", "product_quantity": "40 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 111717E Exp. 11/19"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0609-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Hair & Nails Formula, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955504924, NDC 57955-5049-2", "product_quantity": "210 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 030216C Exp. 03/19; 080916G Exp. 08/19"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "600", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Ketamine 100mg/mL 1mL fill 3 mL syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0709-78", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1294-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lawrence", "state": "KS", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90398", "recalling_firm": "Plastikon Healthcare LLC", "address_1": "3780 Greenway Cir", "address_2": "N/A", "postal_code": "66046-5440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1477-2022", "product_description": "MILK OF MAGNESIA USP, 2400 mg/10 mL, Magnesium Hydroxide, 30 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, NDC 0904-6840-72.", "product_quantity": "7,700 cups", "reason_for_recall": "Microbial Contamination of Non-Sterile Products.", "recall_initiation_date": "20220607", "center_classification_date": "20220906", "termination_date": "20250625", "report_date": "20220914", "code_info": "Lot # 20074A, EXP Jul. 2022"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72699", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0514-2016", "product_description": "Ascorbic Acid 500 MG/ML Inj., Qty: 50 mL Vial, MFG by: Mylan Institutional, Rockford, IL 61103, Repackaged by: RemedyRepack Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 61786-0431-16", "product_quantity": "1 Vial", "reason_for_recall": "Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.", "recall_initiation_date": "20151111", "center_classification_date": "20151204", "termination_date": "20161101", "report_date": "20151216", "code_info": "LOT # B0105052-100715, Exp 07/01/2017", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69553", "recalling_firm": "Actavis Inc", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0232-2015", "product_description": "Vancomycin Hydrochloride Capsule, USP, 125 mg, 20 count blister pack, Rx Only, Mfd. for: Watson Pharma. Inc. Parsippany, NJ 07054 USA, Mfd. by: Patheon Pharmaceuticals Inc. Cincinnati, OH 45237 USA ---- NDC 0591-3560-15 UPC Code 3-0591356015-4", "product_quantity": "26,663 cartons", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20140825", "center_classification_date": "20141030", "termination_date": "20180321", "report_date": "20141105", "code_info": "3103681, exp Aug 2014,  3104886, exp Oct 2014,  3105836, exp Dec 2014, and  3106650, exp Dec 2014", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0466-2020", "product_description": "Natural Ophthalmics Cataract Eye Drops with Cineraria, 15 mL, 25 mL, NDC  68770-130-15", "product_quantity": "61830 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17282 9/19  18121 5/20"}, {"status": "Ongoing", "city": "Bengaluru", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA207522"], "brand_name": ["METHOCARBAMOL"], "generic_name": ["METHOCARBAMOL"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "product_ndc": ["70069-101"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["METHOCARBAMOL"], "rxcui": ["238175"], "spl_id": ["dd175ad9-9f83-4ef1-b745-65e44f5e12c4"], "spl_set_id": ["68dd9c24-4d41-48be-9f54-fceb787bb443"], "package_ndc": ["70069-101-25", "70069-101-10", "70069-101-05"], "is_original_packager": [true], "upc": ["0370069101018", "0370069101100", "0370069101254", "0370069101056"], "nui": ["N0000175730", "N0000175737"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "unii": ["125OD7737X"]}, "product_type": "Drugs", "event_id": "96569", "recalling_firm": "Somerset Therapeutics Private Limited", "address_1": "54/1 Budihal Village", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0354-2025", "product_description": "Methocarbamol Injection USP\t1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton)", "product_quantity": "506,080 vials", "reason_for_recall": "Lack of Assurance of Sterility: Media fill with bacterial contamination", "recall_initiation_date": "20250321", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "NDC 70069-101-25; A240304, A240305, A240320, A240322, A240334, A240335, A240340, exp. date 05/2026;  A240342, A240347, A240385, A240391, exp. date 06/2026;   NDC 70069-101-05;  A240326, exp. date 05/2026"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0746-2019", "product_description": "Dr. King's SafeCare Rx Snore Control Sleep, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955012023, NDC 57955-0120-2", "product_quantity": "198 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 021616B Exp. 02/19; 083016B Exp. 08/19"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA205874"], "brand_name": ["AURYXIA"], "generic_name": ["FERRIC CITRATE"], "manufacturer_name": ["Akebia Therapeutics, Inc."], "product_ndc": ["59922-631"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TETRAFERRIC TRICITRATE DECAHYDRATE"], "rxcui": ["1594680", "1596023"], "spl_id": ["c7578bda-1b89-4881-95cd-f1201508871f"], "spl_set_id": ["aadd18e0-3752-11e4-8510-0800200c9a66"], "package_ndc": ["59922-631-01"], "is_original_packager": [true], "unii": ["Q91187K011"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0499-2021", "product_description": "Auryxia (ferric citrate) tablets 210 mg* 200 Tablets Rx Only NDC 59922-631-01 Manufactured for and distributed by: Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue, 20th Floor New York, NY 10022 USA", "product_quantity": "136 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "AN0142D"}, {"status": "Terminated", "city": "Littleton", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83397", "recalling_firm": "Wise Pharmacy", "address_1": "6179 S Balsam Way Ste 150", "address_2": "N/A", "postal_code": "80123-3095", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CO, TX, WY", "recall_number": "D-1576-2019", "product_description": "Papaverine/Phentolamine/Alprostadil 30 mg/2 mg/50 mcg/mL Injectable, 2.5 mL Vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.", "product_quantity": "32 vials", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20190722", "center_classification_date": "20190731", "termination_date": "20200203", "report_date": "20190807", "code_info": "Lot #: 6176N, Exp 8/30/2019; 7162N, Exp 10/20/2019"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA090383"], "brand_name": ["SIMVASTATIN"], "generic_name": ["SIMVASTATIN"], "manufacturer_name": ["Micro Labs Limited"], "product_ndc": ["42571-005", "42571-010", "42571-020", "42571-040", "42571-080"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SIMVASTATIN"], "rxcui": ["198211", "200345", "312961", "312962", "314231"], "spl_id": ["0369d423-9ef2-0191-e063-6294a90a55e7"], "spl_set_id": ["5c1c694c-4b08-469e-b538-08e69df06146"], "package_ndc": ["42571-010-30", "42571-010-60", "42571-010-90", "42571-010-05", "42571-010-10", "42571-005-30", "42571-005-60", "42571-005-90", "42571-005-05", "42571-005-10", "42571-020-30", "42571-020-60", "42571-020-90", "42571-020-05", "42571-020-10", "42571-040-30", "42571-040-60", "42571-040-90", "42571-040-05", "42571-040-10", "42571-080-30", "42571-080-60", "42571-080-90", "42571-080-05", "42571-080-10"], "is_original_packager": [true], "upc": ["0342571010300", "0342571040307", "0342571020309", "0342571005306", "0342571080303"], "nui": ["N0000175589", "N0000000121"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "unii": ["AGG2FN16EV"]}, "product_type": "Drugs", "event_id": "69268", "recalling_firm": "Micro Labs Usa, Inc                                    S", "address_1": "104 Carnegie Ctr", "address_2": "Te 216", "postal_code": "08540-6232", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY", "recall_number": "D-0246-2015", "product_description": "Simvastatin Tablets, USP, 10 mg, Rx Only, 90 count bottles, Manufactured by: Micro Labs Limited, Goa-403 722, INDIA, Manufactured for: Micro Labs USA Inc., Princeton, NJ 08540, NDC 42571-010-90", "product_quantity": "1,008 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Product failed Impurity content (Butylated Hydroxy Anisole Content) against shelf life specification.", "recall_initiation_date": "20140819", "center_classification_date": "20141112", "termination_date": "20160419", "report_date": "20141119", "code_info": "Lot #: STBG005, Exp 2/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80118", "recalling_firm": "Guardian Pharmacy Services", "address_1": "7920 Elmbrook Dr Ste 108", "address_2": "N/A", "postal_code": "75247-4933", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-1072-2018", "product_description": "MIC \"B\" COMBO LIPOTROPIC 50 ml. Packaged in a 50ml MDV vial. Compounded Guardian Pharmacy Services, 7920 Elmbrook Dr. Ste. 108C Dallas TX 75247", "product_quantity": "250 50-ml vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20180517", "center_classification_date": "20180808", "termination_date": "20201125", "report_date": "20180815", "code_info": "Lots:  58618:42 UB, Use By: 06/10/2018"}, {"status": "Ongoing", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "96329", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "FL and NY", "recall_number": "D-0305-2025", "product_description": "Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5%  2.5%  0.5%, 5 mL fill in 15 mL bottle, Imprimis NJOF, LLC, Route 46 West, Unit 6B, Ledgewood, NJ, 07852, NDC: 71384-733-05.", "product_quantity": "2822 bottles", "reason_for_recall": "Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.", "recall_initiation_date": "20250224", "center_classification_date": "20250328", "report_date": "20250409", "code_info": "Lot 24OCT041, Exp 04/26/2025", "more_code_info": ""}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "5,579 cases", "code_info": "Product Code: 6422; Lots: 57496, 57555, EXP 08/14/2017;  58045, EXP 09/11/2017; 58972, EXP 11/03/2017; 59162EXP 11/13/2017; 59835, EXP 01/02/2018; 60309, EXP 02/05/2018; 61188, EXP 02/23/2018", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Q CARE q2 Oral Cleansing & Suctioning System, Contains 1 Covered Yankauer and Y-Connector, 2 Suction Toothbrush packages with  Antiplaque solution, 4 Suction Oral Swab packages with  Perox-A-Mint solution, 6 Suction Oral Swab packages with Alcohol-Free mouthwash, 4 Oropharyngeal Suction Catheter packages, Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6422 UPC 6 18029 83031 9", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0376-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-990-2013", "product_description": "PROCAINE P/F 20 MG/ML INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "06132013@30, 06272013@27", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211930"], "brand_name": ["METHYLPREDNISOLONE ACETATE"], "generic_name": ["METHYLPREDNISOLONE ACETATE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-313", "55150-314"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRA-ARTICULAR", "INTRALESIONAL", "INTRAMUSCULAR", "SOFT TISSUE"], "substance_name": ["METHYLPREDNISOLONE ACETATE"], "rxcui": ["1358610", "1358617"], "spl_id": ["a0cbcdb5-f657-49f7-8f86-cc5959d69db0"], "spl_set_id": ["a0cbcdb5-f657-49f7-8f86-cc5959d69db0"], "package_ndc": ["55150-313-25", "55150-313-01", "55150-314-25", "55150-314-01"], "is_original_packager": [true], "upc": ["0355150313013", "0355150314010"], "unii": ["43502P7F0P"]}, "product_type": "Drugs", "event_id": "94075", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "OH, TN, LA, MS", "recall_number": "D-0366-2024", "product_description": "Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01", "product_quantity": "10,080 vials", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20240220", "center_classification_date": "20240304", "report_date": "20240313", "code_info": "Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205327"], "brand_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "generic_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "manufacturer_name": ["Trigen Laboratories, LLC"], "product_ndc": ["13811-706", "13811-709", "13811-707", "13811-708", "13811-710"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "rxcui": ["1091155", "1091170", "1091185", "1091210", "1995461"], "spl_id": ["54f7316b-8a84-4145-aecf-f380afbf261b"], "spl_set_id": ["c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"], "package_ndc": ["13811-709-10", "13811-706-10", "13811-707-10", "13811-708-10", "13811-710-10", "13811-710-30"], "is_original_packager": [true], "upc": ["0313811706109", "0313811709100", "0313811708103", "0313811707106"], "unii": ["4B3SC438HI"]}, "product_type": "Drugs", "event_id": "94818", "recalling_firm": "Trigen Laboratories", "address_1": "1880 Mcfarland Pkwy", "address_2": "ste 110", "postal_code": "30005-1794", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0579-2024", "product_description": "Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle, Rx Only, Manufactured for: Trigen Laboratories, LLC, Alpharetta, GA 30005, NDC 13811-708-10", "product_quantity": "10,448 100-count bottles", "reason_for_recall": "Failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications.", "recall_initiation_date": "20240617", "center_classification_date": "20240702", "termination_date": "20250923", "report_date": "20240710", "code_info": "Lot 230159M, Exp Date 2/28/2026"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076658"], "brand_name": ["FLUCONAZOLE"], "generic_name": ["FLUCONAZOLE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-143", "55111-144", "55111-145", "55111-146"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUCONAZOLE"], "rxcui": ["197698", "197699", "197700", "197701"], "spl_id": ["69e67aa4-a859-7ab0-79df-d9bf8489998d"], "spl_set_id": ["d7fa1d79-4cd3-4a55-b74b-b31e82e616a3"], "package_ndc": ["55111-143-30", "55111-143-01", "55111-143-05", "55111-143-79", "55111-143-78", "55111-144-30", "55111-144-01", "55111-144-05", "55111-144-79", "55111-144-78", "55111-145-71", "55111-145-12", "55111-146-30", "55111-146-01", "55111-146-05", "55111-146-79", "55111-146-78"], "is_original_packager": [true], "upc": ["0355111145127"], "nui": ["N0000175487", "M0002083", "N0000182140", "N0000182141", "N0000185504"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_moa": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "unii": ["8VZV102JFY"]}, "product_type": "Drugs", "event_id": "76122", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0450-2017", "product_description": "Flucanozole Tablets, USP, 100 mg, a) 30 count (NDC 55111-144-30) and b) 100 count (NDC 55111-144-01) bottles, Rx Only, Mfd. by: Dr. Reddy's Laboratories, Bachupally 500 090 India", "product_quantity": "a) 42,984 and b) 7,764 bottles", "reason_for_recall": "Failed Dissolution Specifications; 18 month stability time point", "recall_initiation_date": "20161228", "center_classification_date": "20170130", "termination_date": "20171019", "report_date": "20170208", "code_info": "a) 30 count C500224, exp 12/2016, C500846, exp 01/2017  b) 100 count C500224, exp 12/2016, exp 12/2016, C501608, exp 02/2017 and C503655, exp 04/2017", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0208-2019", "product_description": "Trimix T-106 30PA-1PH-25A Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1339-05", "product_quantity": "44 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 03292018:66 Discard by: 9/24/2018; 05312018:81 Discard by: 11/27/2018"}, {"status": "Terminated", "city": "Aiken", "state": "SC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67800", "recalling_firm": "GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline", "address_1": "65 Windham Blvd", "address_2": "N/A", "postal_code": "29805-9384", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1244-2014", "product_description": "Nicorette Lozenge,  Nicoderm CQ, and Nicorette Gum nicotine polacrilex combination.  Contains 30 Pieces/ Pallet.  OTC only.  GlaxoSmithKlein, 1000 GSK Drive, Moon Township, PA 15108. UPC: 0-03-0766-1442-81-2.", "product_quantity": "12,162 Pallets", "reason_for_recall": "Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.", "recall_initiation_date": "20140220", "center_classification_date": "20140418", "termination_date": "20170120", "report_date": "20140430", "code_info": "Lot #12K16W (exp 5/14), 12K27N (exp 6/14), 12K27W (exp 6/14), 12K29N (exp 6/14), 13K20W (exp 6/15), 13K20W1 (exp 6/15) & 13K25N (exp 6/15).", "more_code_info": ""}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Golden State Medical Supply, Inc."], "product_ndc": ["60429-164", "60429-165", "60429-166"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["3a8cefd0-9db7-8cd0-e063-6394a90a5996"], "spl_set_id": ["f535fcd2-a50a-4423-85d9-705fd2d9a470"], "package_ndc": ["60429-164-60", "60429-165-30", "60429-165-90", "60429-166-30", "60429-166-10"], "original_packager_product_ndc": ["51991-746", "51991-747", "51991-748"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "74558", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide. No foreign distribution.", "recall_number": "D-1255-2016", "product_description": "DULOXETINE Delayed-Release Capsules, USP, 60 mg, 1000 count bottles, Rx only, Manufactured by: Laboratorios del Dr. Esteve, SA, Martorelles, Barcelona --- NDC 60429-166-10", "product_quantity": "2077 bottles", "reason_for_recall": "Labeling; Incorrect or Missing Lot and/or Exp Date; incorrect expiration date on container label is 02/2019, correct expiration date should be 02/2018", "recall_initiation_date": "20160628", "center_classification_date": "20160711", "termination_date": "20161128", "report_date": "20160720", "code_info": "Lot# GS011709, GS012352", "more_code_info": ""}, {"status": "Terminated", "city": "Clarence", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89779", "recalling_firm": "Athenex Pharma Solutions, LLC", "address_1": "11342 Main St", "address_2": "N/A", "postal_code": "14031-1718", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0710-2022", "product_description": "Phenylephrine HCl Injection 50 mg per 250 mL in 0.9% Sodium Chloride, 50 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-494-15", "product_quantity": "1,800 bags", "reason_for_recall": "Defective container", "recall_initiation_date": "20220314", "center_classification_date": "20220321", "termination_date": "20220804", "report_date": "20220330", "code_info": "Lot #: F2101652, F2101653, Exp 5/30/22; F2200111, Exp 7/27/22"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75619", "recalling_firm": "Hospira Inc.", "address_1": "600 N Field Dr", "address_2": "N/A", "postal_code": "60045-4835", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0153-2017", "product_description": "Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., Lake Forest IL 60045, NDC 0409-4093-32", "product_quantity": "797,800 ampules", "reason_for_recall": "Lack of Assurance of Sterility: Complaints of broken tips on the ampules.", "recall_initiation_date": "20161101", "center_classification_date": "20161123", "termination_date": "20180828", "report_date": "20161130", "code_info": "Lot  #5 9277EV, 60028EV, 6008EV, Exp 11/1/17"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0406-2024", "product_description": "HYDROmorphone HCl 6 mg/30 mL in 0.9% Sodium Chloride, (Concentration = 0.2mg/ml) 30 mL Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095,  NDC 70004-0300-18, Bar Code 70004030018", "product_quantity": "1,425 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223048451 Exp 11/20/23; 1223048923 Exp 12/07/23; 1223049097 Exp 12/15/23; 1223049129 Exp 12/19/23;", "more_code_info": ""}, {"status": "Terminated", "city": "Overland Park", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69674", "recalling_firm": "Perry Drug Inc.", "address_1": "12200 W 106th St Ste 140", "address_2": "N/A", "postal_code": "66215-2305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and Missouri", "recall_number": "D-0267-2015", "product_description": "HCG Low Dose 10 IU / 0.1 mL, 5 Ml vials, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS ---NDC 88888-2596-17", "product_quantity": "2 vials", "reason_for_recall": "Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141107", "center_classification_date": "20141124", "termination_date": "20151103", "report_date": "20141203", "code_info": "141010I, 11/10/14; 141017F, 11/17/14;", "more_code_info": ""}, {"status": "Terminated", "city": "Long Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73304", "recalling_firm": "Hartley Medical Center Pharmacy, Incorporated", "address_1": "113 W Victoria St", "address_2": "N/A", "postal_code": "90805-2162", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide. No foreign distribution.", "recall_number": "D-0759-2016", "product_description": "Morphine Sulfate 11 mg/ml, vol. 20 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160204", "center_classification_date": "20160304", "termination_date": "20160809", "report_date": "20160316", "code_info": "BUD: 5/3/2016"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0538-2018", "product_description": "Cyanocobalamin USP (Vitamin B12) for prescription compounding, packaged in a) 1g (NDC 58597-8044-1), b) 5g (NDC 58597-8044-2), c) 25g (NDC 58597-8044-4), d) 100g (NDC 58597-8044-6), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 031815-2, Exp. 1/14/2020; b) 031815-2, Exp. 1/14/2020; c) 031815-2, Exp. 1/14/2020; d) 031815-1, Exp. 1/14/2020"}, {"status": "Ongoing", "city": "Panchmahal", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA210560"], "brand_name": ["BROMFENAC OPHTHALMIC SOLUTION 0.09%"], "generic_name": ["BROMFENAC OPHTHALMIC SOLUTION 0.09%"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "product_ndc": ["62332-508"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["BROMFENAC SODIUM"], "rxcui": ["578018"], "spl_id": ["824d37d0-e25f-4df8-be0e-d9a65046fc10"], "spl_set_id": ["225070ee-d862-4d41-84b8-5bd7a8a03fd7"], "package_ndc": ["62332-508-17"], "is_original_packager": [true], "unii": ["8ECV571Y37"]}, "product_type": "Drugs", "event_id": "96836", "recalling_firm": "Alembic Pharmaceuticals Limited", "address_1": "Formulation Division, Village Panelav, P.O. Tajpura, Near Baska, Taluka Halol", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0447-2025", "product_description": "Bromfenac Ophthalmic Solution 0.09%, 1.7 mL bottle, Rx only, Sterile, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, Manufactured by Alembic Pharmaceuticals Limitied, Gujarat, India, Made in India, NDC 62332-508-17", "product_quantity": "N/A", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20250507", "center_classification_date": "20250527", "report_date": "20250604", "code_info": "Lot 7230309, Exp Date: 5/31/2025; Lot 7230310, Exp Date: 5/31/2025; Lot 7230311, Exp Date: 5/31/2025"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82615", "recalling_firm": "Customceutical Compounding", "address_1": "4611 E Shea Blvd Bldg 3 Ste 180", "address_2": "N/A", "postal_code": "85028-4258", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1257-2019", "product_description": "Lipoplex (METHIONINE 25 MG/ML INOSITOL 50 MG/ML CHOLINE CHLORIDE 50 MG/ML HYDROXOCOBALAMIN 500 MC/ML DEXPANTHENOL 50 MG/ML PYRIDOXINE HCL 50 MG/ML), 10 ML MULTIDOSE VIAL INJ COMPOUNDED. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272", "product_quantity": "16 vials", "reason_for_recall": "Lack of assurance of sterility for injectables and solutions intended to be sterile.", "recall_initiation_date": "20190408", "center_classification_date": "20190430", "termination_date": "20230519", "report_date": "20190508", "code_info": "Lot #: 02212019@13, Exp 5/22/19"}]